Total investments received (USD): 9.76m
Round value (USD): 2.28m
Round investors:
Cambridge Enterprise
Company: PharmEnable


Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain